Literature DB >> 24069778

Pregnancy, obstetric and neonatal outcomes in HIV positive Nigerian women.

O C Ezechi1, C V Gab-Okafor, D A Oladele, O O Kalejaiye, B O Oke, H O Ohwodo, R A Adu, S O Ekama, Z Musa, D I Onwujekwe, A N David, I A O Ujah.   

Abstract

While the effect of HIV infection on some maternal outcomes is well established, for some others there is conflicting information on possible association with HIV. In this study we investigated pregnancy and neonatal outcome of HIV positive women in large HIV treatment centre over a period of 84 months. They were managed according to the Nigerian PMTCT protocol. Adverse obstetric and neonatal outcome were observed in 48.3% HIV positives compared 30.3% to the negatives (OR: 2.08; CI: 1.84-2.34). Low birth weight ( OR:2.95; CI:1.95-3.1), preterm delivery (OR:2.05; CI:1.3-3.1), perinatal death (OR:1.9;CI:1.3-3.2), and spontaneous abortion (OR:1.37; CI:1.1-2.3) were factors found to be independently associated with HIV. Low CD4 count (OR: 2.45; CI: 1.34- 4.56) and opportunistic infections (OR: 2.11; CI: 1.56-3.45) were to be associated with adverse obstetric and neonatal outcome. This study confirms the association of HIV, severe immunosuppression and opportunistic infection and adverse obstetric and neonatal outcome.

Entities:  

Mesh:

Year:  2013        PMID: 24069778

Source DB:  PubMed          Journal:  Afr J Reprod Health        ISSN: 1118-4841


  22 in total

1.  Maternal post-absorptive leucine kinetics during late pregnancy in US women with HIV taking antiretroviral therapy: a cross-sectional pilot study.

Authors:  W Todd Cade; Gautam K Singh; Mark R Holland; Dominic N Reeds; E Turner Overton; Nancy Cibulka; Karen Bahow; Rachel Presti; Andrea Stephens; Alison G Cahill
Journal:  Clin Nutr ESPEN       Date:  2015-08-01

2.  Association of previous severe low birth weight with adverse perinatal outcomes in a subsequent pregnancy among HIV-prevalent urban African women.

Authors:  Marcela C Smid; Yusuf Ahmed; Marie C D Stoner; Bellington Vwalika; Elizabeth M Stringer; Jeffrey S A Stringer
Journal:  Int J Gynaecol Obstet       Date:  2016-11-30       Impact factor: 3.561

3.  Reassuring Birth Outcomes With Tenofovir/Emtricitabine/Efavirenz Used for Prevention of Mother-to-Child Transmission of HIV in Botswana.

Authors:  Rebecca Zash; Sajini Souda; Jennifer Y Chen; Kelebogile Binda; Scott Dryden-Peterson; Shahin Lockman; Mompati Mmalane; Joseph Makhema; Max Essex; Roger Shapiro
Journal:  J Acquir Immune Defic Syndr       Date:  2016-04-01       Impact factor: 3.731

4.  Cryptococcosis in pregnancy and the postpartum period: Case series and systematic review with recommendations for management.

Authors:  Katelyn A Pastick; Elizabeth Nalintya; Lillian Tugume; Kenneth Ssebambulidde; Nicole Stephens; Emily E Evans; Jane Frances Ndyetukira; Edwin Nuwagira; Caleb Skipper; Conrad Muzoora; David B Meya; Joshua Rhein; David R Boulware; Radha Rajasingham
Journal:  Med Mycol       Date:  2020-04-01       Impact factor: 4.076

5.  Timing of Initiation of Antiretroviral Therapy and Risk of Preterm Birth in Studies of HIV-infected Pregnant Women: The Role of Selection Bias.

Authors:  Marie C D Stoner; Stephen R Cole; Joan Price; Jennifer Winston; Jeffrey S A Stringer
Journal:  Epidemiology       Date:  2018-03       Impact factor: 4.822

6.  Predictors of adverse pregnancy outcomes among Kenyan women with HIV on antiretroviral treatment in pregnancy.

Authors:  Wenwen Jiang; Keshet Ronen; Lusi Osborn; Alison L Drake; Jennifer A Unger; Daniel Matemo; Daniel A Enquobahrie; John Kinuthia; Grace John-Stewart
Journal:  AIDS       Date:  2022-03-04       Impact factor: 4.632

7.  Miscarriage among women in the United States Women's Interagency HIV Study, 1994-2017.

Authors:  Kristin M Wall; Lisa B Haddad; C Christina Mehta; Elizabeth T Golub; Lisa Rahangdale; Jodie Dionne-Odom; Roksana Karim; Rodney L Wright; Howard Minkoff; Mardge Cohen; Seble G Kassaye; Deborah Cohan; Igho Ofotokun; Susan E Cohn
Journal:  Am J Obstet Gynecol       Date:  2019-05-25       Impact factor: 10.693

8.  Behavioral Interventions can Mitigate Adverse Pregnancy Outcomes Among Women Conceiving on ART and Those Initiated on ART During Pregnancy: Findings From the MOTIVATE Trial in Southwestern Kenya.

Authors:  Maricianah Onono; Tobias Odwar; Samuel Wahome; Anna Helova; Elizabeth Anne Bukusi; Karen Hampanda; Janet Turan; Lisa Abuogi
Journal:  J Acquir Immune Defic Syndr       Date:  2021-01-01       Impact factor: 3.771

9.  Prenatal testing and prevalence of HIV infection during pregnancy: data from the "Birth in Brazil" study, a national hospital-based study.

Authors:  Rosa Maria Soares Madeira Domingues; Celia Landmann Szwarcwald; Paulo Roberto Borges Souza; Maria do Carmo Leal
Journal:  BMC Infect Dis       Date:  2015-02-26       Impact factor: 3.090

10.  Prevention of Mother-to-Child Transmission and Early Real-Time DNA Polymerase Chain Reaction Results Among HIV-Exposed Infants in Bujumbura, Burundi.

Authors:  Joseph Nyandwi; Sylvestre Bazikamwe; Désiré Nisubire; Pontien Ndabashinze; Mohamed Elsayed Shaker; Eman Said
Journal:  East Afr Health Res J       Date:  2018-11-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.